Xue Bai
- Molecular Biology top 5%
- Cancer Research top 2%
- Immunology top 5%
- Epidemiology top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Co-authors
- Baofeng YangYong ZhangZhange LiChaoqian XuXin LiuJiamin LiHuan YangXianxian Wu
- Topics
- MicroRNA in disease regulation (11 papers)RNA modifications and cancer (8 papers)Cancer-related molecular mechanisms research (8 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xue Bai
82 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Molecular Biology 1.9k
- Cancer Research 663
- Immunology 468
- Epidemiology 348
- Cardiology and Cardiovascular Medicine 342
Countries citing papers authored by Xue Bai
This map shows the geographic impact of Xue Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Bai more than expected).
Fields of papers citing papers by Xue Bai
This network shows the impact of papers produced by Xue Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Bai. The network helps show where Xue Bai may publish in the future.
Co-authorship network of co-authors of Xue Bai
This figure shows the co-authorship network connecting the top 25 collaborators of Xue Bai. A scholar is included among the top collaborators of Xue Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Bai. Xue Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 13 | |
| 8 | 2 | |
| 9 | 59 | |
| 10 | Serum 14-3-3η Could Improve the Diagnostic Rate of Rheumatoid Arthritis and Correlates to Disease Activity. | 16 |
| 11 | 4 | |
| 12 | 42 | |
| 13 | 3 | |
| 14 | 130 | |
| 15 | 25 | |
| 16 | 32 | |
| 17 | 18 | |
| 18 | 60 | |
| 19 | 37 | |
| 20 | 44 |
About Xue Bai
Xue Bai is a scholar working on Cancer Research, Geriatrics and Gerontology and Molecular Biology, having authored 87 papers that have together received 3.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (663 citations), Molecular Biology (1.9k citations) and Immunology (468 citations). Xue Bai has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Baofeng Yang, Yong Zhang, Zhange Li, Chaoqian Xu, Xin Liu, Jiamin Li, Huan Yang, Xianxian Wu, Lin Yuan and Xiaohong Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.